Nalidixic acid USP27 en es it fr

Nalidixic acid USP27 Brand names, Nalidixic acid USP27 Analogs

Nalidixic acid USP27 Brand Names Mixture

  • No information avaliable

Nalidixic acid USP27 Chemical_Formula

C10H15N3

Nalidixic acid USP27 RX_link

No information avaliable

Nalidixic acid USP27 fda sheet

Nalidixic acid USP27 msds (material safety sheet)

Nalidixic acid USP27 Synthesis Reference

No information avaliable

Nalidixic acid USP27 Molecular Weight

177.25 g/mol

Nalidixic acid USP27 Melting Point

196 oC

Nalidixic acid USP27 H2O Solubility

207 mg/L

Nalidixic acid USP27 State

Solid

Nalidixic acid USP27 LogP

1.493

Nalidixic acid USP27 Dosage Forms

Tablet for oral administration

Nalidixic acid USP27 Indication

For the treatment of hypertension.

Nalidixic acid USP27 Pharmacology

Betanidine is a guanidinium antihypertensive agent that acts by blocking adrenergic transmission. The precise mode of action is not clear. Although bethanidine may produce adverse effects, they are beneficial in severe hypertension and produce fewer side effects than guanethidine.

Nalidixic acid USP27 Absorption

Absorbed rapidly in the gastrointestinal tract following oral administration.

Nalidixic acid USP27 side effects and Toxicity

No information avaliable

Nalidixic acid USP27 Patient Information

No information avaliable

Nalidixic acid USP27 Organisms Affected

Humans and other mammals